Super-Dragon Engineering Plastics
301131
Broadex Technologies
300548
Zhejiang Zhaofeng Mechanical And Electronic
300695
4
Jing-Jin Electric Technologies
688280
5
Hangzhou Anysoft Information Technology
300571
US Stock MarketDetailed Quotes
CYCC Cyclacel Pharmaceuticals
- 0.2853
- +0.0068+2.44%
Close Apr 28 16:00 ET
- 0.2311
- -0.0542-19.00%
Pre 07:28 ET
59.15MMarket Cap-0.14P/E (TTM)
0.4198High0.2500Low10.98MVolume0.2986Open0.2785Pre Close3.72MTurnover86.41%Turnover RatioLossP/E (Static)207.34MShares3.083552wk High-28.53P/B3.63MFloat Cap0.170652wk Low--Dividend TTM12.71MShs Float2141994.0840Historical High--Div YieldTTM60.97%Amplitude0.1706Historical Low0.3380Avg Price1Lot Size
Cyclacel Pharmaceuticals Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -89.76%43K | 0 | -37.50%10K | -98.93%4K | 29K | 420K | 31K | 16K | 373K | 0 |
| Operating revenue | -89.76%43K | --0 | -37.50%10K | -98.93%4K | --29K | --420K | --31K | --16K | --373K | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | -53.44%12.05M | -66.09%1.83M | -68.12%2.19M | -42.11%3.65M | -40.10%4.38M | -6.45%25.87M | -39.05%5.39M | 6.09%6.86M | 8.94%6.3M | 11.59%7.32M |
| Selling and administrative expenses | -19.74%5.39M | -49.39%948K | -23.88%1.24M | 3.17%1.63M | -3.83%1.58M | -8.99%6.72M | -12.60%1.87M | -20.89%1.63M | -0.32%1.58M | 2.49%1.65M |
| -General and administrative expense | -19.74%5.39M | -49.39%948K | -23.88%1.24M | 3.17%1.63M | -3.83%1.58M | -8.99%6.72M | -12.60%1.87M | -20.89%1.63M | -0.32%1.58M | 2.49%1.65M |
| Research and development costs | -65.26%6.66M | -74.99%880K | -81.86%950K | -57.20%2.02M | -50.62%2.8M | -5.52%19.16M | -47.51%3.52M | 18.65%5.24M | 12.41%4.73M | 14.53%5.67M |
| Operating profit | 52.84%-12M | 65.90%-1.83M | 68.20%-2.18M | 38.54%-3.64M | 40.50%-4.36M | 7.97%-25.45M | 39.40%-5.36M | -5.85%-6.85M | -2.49%-5.93M | -11.59%-7.32M |
| Net non-operating interest income expense | -95.49%12K | 30.43%30K | -84.00%8K | -136.36%-28K | -98.28%2K | 26.67%266K | -81.15%23K | -25.37%50K | 352.94%77K | 2,800.00%116K |
| Non-operating interest income | -95.49%12K | ---- | -84.00%8K | ---- | -98.28%2K | 26.67%266K | -81.15%23K | -25.37%50K | 352.94%77K | 2,800.00%116K |
| Non-operating interest expense | ---- | ---- | ---- | --28K | ---- | ---- | ---- | ---- | ---- | ---- |
| Other net income (expense) | 99.45%-2K | 83.15%-60K | -97.89%2K | 101.65%3K | -32.91%53K | -123.78%-364K | -28.52%-356K | -67.24%95K | -187.08%-182K | -93.96%79K |
| Gain on sale of security | 86.96%-54K | 83.15%-60K | -98.08%2K | 103.95%3K | 101.15%1K | -277.68%-414K | -26.69%-356K | -62.32%104K | -136.36%-76K | -400.00%-87K |
| Other non- operating income (expenses) | 4.00%52K | --0 | ---- | ---- | -68.67%52K | -96.15%50K | --0 | -164.29%-9K | ---106K | -87.03%166K |
| Income before tax | 53.06%-11.99M | 67.36%-1.86M | 67.66%-2.17M | 39.19%-3.67M | 39.64%-4.3M | 1.40%-25.55M | 36.74%-5.69M | -9.66%-6.7M | -8.54%-6.03M | -35.80%-7.12M |
| Income tax | 73.90%-782K | 382.94%1.19M | 68.56%-210K | 29.69%-412K | -2.58%-1.35M | 36.49%-3M | 73.31%-422K | 34.12%-668K | 40.45%-586K | -15.99%-1.32M |
| Net income | 50.29%-11.21M | 42.10%-3.05M | 67.56%-1.96M | 40.22%-3.26M | 49.24%-2.95M | -6.40%-22.56M | 28.95%-5.27M | -18.37%-6.03M | -19.08%-5.45M | -41.29%-5.8M |
| Net income continuous Operations | 50.29%-11.21M | 42.10%-3.05M | 67.56%-1.96M | 40.22%-3.26M | 49.24%-2.95M | -6.40%-22.56M | 28.95%-5.27M | -18.37%-6.03M | -19.08%-5.45M | -41.29%-5.8M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | 50.29%-11.21M | 42.10%-3.05M | 67.56%-1.96M | 40.22%-3.26M | 49.24%-2.95M | -6.40%-22.56M | 28.95%-5.27M | -18.37%-6.03M | -19.08%-5.45M | -41.29%-5.8M |
| Preferred stock dividends | 0.00%201K | 0.00%50K | 0.00%50K | 0.00%50K | 0.00%50K | |||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 50.73%-11.21M | 42.64%-3.05M | 67.82%-1.96M | 40.76%-3.26M | 49.68%-2.95M | -6.34%-22.76M | 28.76%-5.32M | -18.19%-6.08M | -18.88%-5.5M | -40.79%-5.85M |
| Basic earnings per share | 92.19%-2.09 | 94.70%-0.33 | 62.50%-0.18 | 89.04%-0.72 | 67.57%-2.27 | 6.79%-26.75 | 30.78%-6.23 | 92.56%-0.48 | 4.78%-6.57 | -11.11%-7 |
| Diluted earnings per share | 92.19%-2.09 | 94.70%-0.33 | 62.50%-0.18 | 89.04%-0.72 | 67.57%-2.27 | 6.79%-26.75 | 30.78%-6.23 | 92.56%-0.48 | 4.78%-6.57 | -11.11%-7 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- |
Market Insights
Discussing
Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks
Moo Earnings
Feb 17 19:21
Alibaba Q4 FY2024 Earnings Preview: Predict & Win Big! 🚀